Global Anti-tumor Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era. The global market for Anti-tumor Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. In China, Anti-tumor Drug key players include AstraZeneca, Merck & Co., Roche, Celgene, Johnson & Johnson, etc. United States is the largest market, followed by Japan, and Europe. Report Scope This report aims to provide a comprehensive presentation of the global market for Anti-tumor Drug, with both...Read more | USD 5,900.00 |
Global Thin Film Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. The global market for Thin Film Drugs was estimated to be worth US$ 7709 million in 2023 and is forecast to a readjusted size of US$ 14280 million by 2030 with a CAGR of 9.1% during the forecast period 2024-2030. Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%. Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent. In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is...Read more | USD 5,900.00 |
Global Cell Sorting Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030Cell sorting is the ability to separate cells according to their properties. These properties can be described as intracellular (inside the cell) or extracellular (outside the cell). Intracellular processes can include DNA, RNA and protein molecule interaction, whereas extracellular physical properties include size, shape (morphology), and surface protein expression. The global market for Cell Sorting was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. In EMEA (Europe, Middle East and Africa) Cell Sorting key players include Becton, Dickinson and Company, Beckman Coulter, Bio-Rad Laboratories, Miltenyi Biotec GmbH, etc. Global top four manufacturers hold a share about 80%. Europe is the largest market, with a share over 85%, followed by Africa, and Middle East, both have a share about 10 percent. In terms of product, Fluorescent Activated Cell Sorting...Read more | USD 5,900.00 |
Global Sudden Eye Pain Relief Treatment Market Research Report 2024Acute ocular pain, commonly referred to as sudden and severe eye pain, is a distressing condition that demands prompt attention. It can originate from various causes, ranging from mild to severe, and requires careful evaluation for accurate diagnosis and timely treatment. The causes of acute ocular pain are diverse, encompassing both external and internal factors. The global Sudden Eye Pain Relief Treatment market was valued at US$ 402 million in 2023 and is anticipated to reach US$ 738 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030. The global acute ocular pain market is experiencing tremendous growth due to various key factors. One of the primary drivers is the increasing aging population. The aging population contributes significantly to the increasing prevalence of acute ocular pain. Elderly people are more susceptible to ocular conditions that can lead to pain and inflammation and require immediate treatment. Due to this, there is...Read more | USD 2,900.00 |
Global Healthcare BPO Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030Healthcare business process outsourcing (BPO) is a practice in which healthcare organizations outsource business operations to outside vendors. The global market for Healthcare BPO was estimated to be worth US$ 193190 million in 2023 and is forecast to a readjusted size of US$ 346500 million by 2030 with a CAGR of 8.6% during the forecast period 2024-2030. Global Healthcare BPO key players include Quintiles, HCL, Cognizant, Inventiv, Lonza, etc. United States is the largest market, with a share about 30%, followed by Asia, and Europe, both have a share about 50 percent. In terms of product, Healthcare Provider BPO is the largest segment, with a share over 30%. Report Scope This report aims to provide a comprehensive presentation of the global market for Healthcare BPO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current...Read more | USD 5,900.00 |